Drug
Azacitadine
Azacitadine: highest development phase Phase 1/2, developed by AbbVie. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- AbbVie
Trials
| Drug | Phase | Indication |
|---|---|---|
| azacitadine NCT02265731 | Phase 1/2 | Non-Hodgkin Lymphoma (NHL) |
Latest
No recent events.
Follow Azacitadine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.